Simulations Plus, Inc.
Simulations Plus releases software for pharmaceutical formulation research
Published in Law and Health Weekly, May 13th, 2006
DDDPlus (Dose Disintegration and Dissolution Plus) is unique software for pharmaceutical formulation research scientists that enables them to predict how changes in drug formulation or changes in experimental setup are likely to affect dissolution rate. Dissolution rate is a critical parameter in the development of drug dosage forms, in making generic versions of existing drugs, and in quality control for production.
Software developed by Simulations...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Cell Therapeutics, Inc.
Cell Therapeutics, Inc. granted U.S. patent for antitubulin agents with anti-cancer activity - Columbia University, New York
Cyclophilin A and TRIM5 alpha independently regulate HIV infectivity - DUA Pharmaceuticals, Inc.
DUSA Pharmaceuticals and New England Compounding Center announce favorable settlement - Federal University of Minas Gerais
Botulinum A toxin injected into gastric wall was safe treatment option for class III obesity - Grant Life Sciences, Inc.
DTL to develop, commercialize Grant's cervical cancer-diagnostic technology - Healthcare Coverage
Centers for Medicare and Medicaid Services (CMS) advises Niaspan is now Part D-eligible - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
